Exogenous Hydrogen Sulfide Induces A375 Melanoma Cell Apoptosis Through Overactivation of the Unfolded Protein Response

References

• Liu D, Lin JR, Robitschek EJ, et al. Evolution of delayed resistance to immunotherapy in a melanoma responder. Nat Med. 2021;27(6):985–992. doi:10.1038/s41591-021-01331-8
   PubMed Web of Science ®Google Scholar
• Schadendorf D, van Akkooi ACJ, Berking C, et al. Melanoma. Lancet. 2018;392(10151):971–984. doi:10.1016/S0140-6736(18)31559-9
   PubMed Web of Science ®Google Scholar
• Millington GW. Mutations of the BRAF gene in human cancer, by Davies et al. (Nature 2002;417:949–54). Clin Exp Dermatol. 2013;38(2):222–223. doi:10.1111/ced.12015
   PubMed Web of Science ®Google Scholar
• Long GV, Weber JS, Infante JR, et al. Overall survival and durable responses in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib combined with trametinib. J Clin Oncol. 2016;34(8):871–878. doi:10.1200/JCO.2015.62.9345
   PubMed Web of Science ®Google Scholar
• Hughes T, Klairmont M, Sharfman WH, Kaufman HL. Interleukin-2, Ipilimumab, and Anti-PD-1: clinical management and the evolving role of immunotherapy for the treatment of patients with metastatic melanoma. Cancer Biol Ther. 2021;22(10–12):513–526. doi:10.1080/15384047.2015.1095401
   PubMed Web of Science ®Google Scholar
• Candido S, Salemi R, Piccinin S, et al. The PIK3CA H1047R mutation confers resistance to BRAF and MEK inhibitors in A375 melanoma cells through the cross-activation of MAPK and PI3K-Akt pathways. Pharmaceutics. 2022;14(3):590. doi:10.3390/pharmaceutics14030590
   PubMed Web of Science ®Google Scholar
• Patel M, Eckburg A, Gantiwala S, et al. Resistance to molecularly targeted therapies in melanoma. Cancers. 2021;13(5):1115. doi:10.3390/cancers13051115
   PubMed Web of Science ®Google Scholar
• Stachyra-Strawa P, Ciesielka M, Janiszewski M, Grzybowska-Szatkowska L. The role of immunotherapy and molecular‑targeted therapy in the treatment of melanoma (Review). Oncol Rep. 2021;46(2):158.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Pascual J, Ayuso-Sacido A, Belda-Iniesta C. Drug resistance in cancer immunotherapy: new strategies to improve checkpoint inhibitor therapies. Cancer Drug Resist. 2019;2(4):980–993. doi:10.20517/cdr.2019.61
   PubMedGoogle Scholar
• Chen G, Davies MA. Targeted therapy resistance mechanisms and therapeutic implications in melanoma. Hematol Oncol Clin North Am. 2014;28(3):523–536. doi:10.1016/j.hoc.2014.03.001
   PubMed Web of Science ®Google Scholar
• Chawla-Sarkar M, Bae SI, Reu FJ, Jacobs BS, Lindner DJ, Borden EC. Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis. Cell Death Differ. 2004;11(8):915–923. doi:10.1038/sj.cdd.4401416
   PubMed Web of Science ®Google Scholar
• Zhong J, Yan W, Wang C, et al. BRAF inhibitor resistance in melanoma: mechanisms and alternative therapeutic strategies. Curr Treat Options Oncol. 2022;23(11):1503–1521. doi:10.1007/s11864-022-01006-7
   PubMed Web of Science ®Google Scholar
• Neophytou CM, Trougakos IP, Erin N, Papageorgis P. Apoptosis deregulation and the development of cancer multi-drug resistance. Cancers. 2021;13(17):4363. doi:10.3390/cancers13174363
   PubMed Web of Science ®Google Scholar
• Tsuruo T, Naito M, Tomida A, et al. Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal. Cancer Sci. 2003;94(1):15–21. doi:10.1111/j.1349-7006.2003.tb01345.x
   PubMed Web of Science ®Google Scholar
• Carneiro BA, El-Deiry WS. Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol. 2020;17(7):395–417. doi:10.1038/s41571-020-0341-y
   PubMed Web of Science ®Google Scholar
• Mohammad RM, Muqbil I, Lowe L, et al. Broad targeting of resistance to apoptosis in cancer. Semin Cancer Biol. 2015;35:S78–S103. doi:10.1016/j.semcancer.2015.03.001
   PubMed Web of Science ®Google Scholar
• Vandiver M, Snyder SH. Hydrogen sulfide: a gasotransmitter of clinical relevance. J Mol Med. 2012;90(3):255–263. doi:10.1007/s00109-012-0873-4
   PubMed Web of Science ®Google Scholar
• Hartle MD, Pluth MD. A practical guide to working with H(2)S at the interface of chemistry and biology. Chem Soc Rev. 2016;45(22):6108–6117. doi:10.1039/C6CS00212A
   PubMed Web of Science ®Google Scholar
• Sun Y, Huang Y, Zhang R, et al. Hydrogen sulfide upregulates KATP channel expression in vascular smooth muscle cells of spontaneously hypertensive rats. J Mol Med. 2015;93(4):439–455. doi:10.1007/s00109-014-1227-1
   PubMed Web of Science ®Google Scholar
• Kimura Y, Kimura H. Hydrogen sulfide protects neurons from oxidative stress. FASEB J. 2004;18(10):1165–1167. doi:10.1096/fj.04-1815fje
   PubMedGoogle Scholar
• Ma Z, Bi Q, Wang Y. Hydrogen sulfide accelerates cell cycle progression in oral squamous cell carcinoma cell lines. Oral Dis. 2015;21(2):156–162. doi:10.1111/odi.12223
   PubMed Web of Science ®Google Scholar
• Wu D, Li J, Zhang Q, et al. Exogenous Hydrogen Sulfide Regulates the Growth of Human Thyroid Carcinoma Cells. Oxid Med Cell Longev. 2019;2019:6927298. doi:10.1155/2019/6927298
   PubMed Web of Science ®Google Scholar
• Wu D, Si W, Wang M, Lv S, Ji A, Li Y. Hydrogen sulfide in cancer: friend or foe? Nitric Oxide. 2015;50:38–45. doi:10.1016/j.niox.2015.08.004
   PubMed Web of Science ®Google Scholar
• Panza E, De Cicco P, Armogida C, et al. Role of the cystathionine gamma lyase/hydrogen sulfide pathway in human melanoma progression. Pigment Cell Melanoma Res. 2015;28(1):61–72. doi:10.1111/pcmr.12312
   PubMed Web of Science ®Google Scholar
• De Cicco P, Panza E, Ercolano G, et al. ATB-346, a novel hydrogen sulfide-releasing anti-inflammatory drug, induces apoptosis of human melanoma cells and inhibits melanoma development in vivo. Pharmacol Res. 2016;114:67–73. doi:10.1016/j.phrs.2016.10.019
   PubMed Web of Science ®Google Scholar
• Shain AH, Bastian BC. From melanocytes to melanomas. Nat Rev Cancer. 2016;16(6):345–358. doi:10.1038/nrc.2016.37
   PubMed Web of Science ®Google Scholar
• Falzone L, Bordonaro R, Libra M, et al. SnapShot: cancer chemotherapy. Cell. 2023;186(8):1816–1816.e1. doi:10.1016/j.cell.2023.02.038
   Google Scholar
• Karapetyan L, Kirkwood JM. State of melanoma: an historic overview of a field in transition. Hematol Oncol Clin North Am. 2021;35(1):1–27. doi:10.1016/j.hoc.2020.09.003
   PubMed Web of Science ®Google Scholar
• Gupta A, Gomes F, Lorigan P. The role for chemotherapy in the modern management of melanoma. Melanoma Manag. 2017;4(2):125–136. doi:10.2217/mmt-2017-0003
   PubMedGoogle Scholar
• Soengas MS, Lowe SW. Apoptosis and melanoma chemoresistance. Oncogene. 2003;22(20):3138–3151. doi:10.1038/sj.onc.1206454
   PubMed Web of Science ®Google Scholar
• Pistritto G, Trisciuoglio D, Ceci C, Garufi A, D’Orazi G. Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies. Aging. 2016;8(4):603–619. doi:10.18632/aging.100934
   PubMedGoogle Scholar
• Lee ZW, Teo XY, Tay EY, et al. Utilizing hydrogen sulfide as a novel anti-cancer agent by targeting cancer glycolysis and pH imbalance. Br J Pharmacol. 2014;171(18):4322–4336. doi:10.1111/bph.12773
   PubMed Web of Science ®Google Scholar
• Lu S, Gao Y, Huang X, Wang X. GYY4137, a hydrogen sulfide (H(2)S) donor, shows potent anti-hepatocellular carcinoma activity through blocking the STAT3 pathway. Int J Oncol. 2014;44(4):1259–1267. doi:10.3892/ijo.2014.2305
   PubMed Web of Science ®Google Scholar
• Yang CT, Zhao Y, Xian M, et al. A novel controllable hydrogen sulfide-releasing molecule protects human skin keratinocytes against methylglyoxal-induced injury and dysfunction. Cell Physiol Biochem. 2014;34(4):1304–1317. doi:10.1159/000366339
   PubMedGoogle Scholar
• Murata T, Sato T, Kamoda T, Moriyama H, Kumazawa Y, Hanada N. Differential susceptibility to hydrogen sulfide-induced apoptosis between PHLDA1-overexpressing oral cancer cell lines and oral keratinocytes: role of PHLDA1 as an apoptosis suppressor. Exp Cell Res. 2014;320(2):247–257. doi:10.1016/j.yexcr.2013.10.023
   PubMed Web of Science ®Google Scholar
• Cao X, Ding L, Xie ZZ, et al. A review of hydrogen sulfide synthesis, metabolism, and measurement: is modulation of hydrogen sulfide a novel therapeutic for cancer? Antioxid Redox Signal. 2019;31(1):1–38. doi:10.1089/ars.2017.7058
   PubMed Web of Science ®Google Scholar
• Xiao Q, Ying J, Qiao Z, et al. Exogenous hydrogen sulfide inhibits human melanoma cell development via suppression of the PI3K/AKT/ mTOR pathway. J Dermatol Sci. 2020;98(1):26–34. doi:10.1016/j.jdermsci.2020.02.004
   PubMed Web of Science ®Google Scholar
• Lempradl A, Pospisilik JA, Penninger JM. Exploring the emerging complexity in transcriptional regulation of energy homeostasis. Nat Rev Genet. 2015;16(11):665–681. doi:10.1038/nrg3941
   PubMed Web of Science ®Google Scholar
• Shi W, Ma W, Xiong L, Zhang M, Tang C. Adaptation with transcriptional regulation. Sci Rep. 2017;7(1):42648. doi:10.1038/srep42648
   PubMedGoogle Scholar
• Zhu G, Lee AS. Role of the unfolded protein response, GRP78 and GRP94 in organ homeostasis. J Cell Physiol. 2015;230(7):1413–1420. doi:10.1002/jcp.24923
   PubMed Web of Science ®Google Scholar
• Doyle KM, Kennedy D, Gorman AM, Gupta S, Healy SJ, Samali A. Unfolded proteins and endoplasmic reticulum stress in neurodegenerative disorders. J Cell Mol Med. 2011;15(10):2025–2039. doi:10.1111/j.1582-4934.2011.01374.x
   PubMed Web of Science ®Google Scholar
• Ellgaard L, McCaul N, Chatsisvili A, Braakman I. Co- and Post-Translational Protein Folding in the ER. Traffic. 2016;17(6):615–638. doi:10.1111/tra.12392
   PubMed Web of Science ®Google Scholar
• Bravo R, Parra V, Gatica D, et al. Endoplasmic reticulum and the unfolded protein response: dynamics and metabolic integration. Int Rev Cell Mol Biol. 2013;301:215–290. doi:10.1016/B978-0-12-407704-1.00005-1
   PubMed Web of Science ®Google Scholar
• van der Voorn JP, van Kollenburg B, Bertrand G, et al. The unfolded protein response in vanishing white matter disease. J Neuropathol Exp Neurol. 2005;64(9):770–775. doi:10.1097/01.jnen.0000178446.41595.3a
   PubMed Web of Science ®Google Scholar
• Adams CJ, Kopp MC, Larburu N, Nowak PR, Ali MMU. Structure and molecular mechanism of ER stress signaling by the unfolded protein response signal activator IRE1. Front Mol Biosci. 2019;6:11.
   PubMed Web of Science ®Google Scholar
• Hetz C. The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat Rev Mol Cell Biol. 2012;13(2):89–102. doi:10.1038/nrm3270
   PubMed Web of Science ®Google Scholar
• Hetz C, Zhang K, Kaufman RJ. Mechanisms, regulation and functions of the unfolded protein response. Nat Rev Mol Cell Biol. 2020;21(8):421–438. doi:10.1038/s41580-020-0250-z
   PubMed Web of Science ®Google Scholar
• Soltanmohammadi E, Farmaki E, Zhang Y, et al. Coordination in the unfolded protein response during aging in outbred deer mice. Exp Gerontol. 2021;144:111191. doi:10.1016/j.exger.2020.111191
   PubMed Web of Science ®Google Scholar